Spaces:
Runtime error
Runtime error
ajitrajasekharan
commited on
Commit
·
c63015b
1
Parent(s):
d273f14
Update app.py
Browse files
app.py
CHANGED
@@ -163,7 +163,7 @@ sent_arr_masked = [
|
|
163 |
"He was diagnosed with non:__entity__ small:__entity__ cell:__entity__ lung:__entity__ cancer:__entity__",
|
164 |
"There are no treatment options specifically indicated for ACD:__entity__ and physicians must utilize agents approved for other dermatology conditions",
|
165 |
"As ACD:__entity__ has been implicated in apoptosis-resistant glioblastoma (GBM), there is a high medical need for identifying novel ACD-inducing drugs ",
|
166 |
-
"Patients treated with anticancer chemotherapy drugs ( ACD:__entity__ ) are vulnerable to infectious diseases due to immunosuppression and to the direct impact of ACD
|
167 |
"In the LASOR:__entity__ trial:__entity__ , increasing daily imatinib dose from 400 to 600mg induced MMR at 12 and 24 months in 25% and 36% of the patients, respectively, who had suboptimal cytogenetic responses "
|
168 |
]
|
169 |
|
|
|
163 |
"He was diagnosed with non:__entity__ small:__entity__ cell:__entity__ lung:__entity__ cancer:__entity__",
|
164 |
"There are no treatment options specifically indicated for ACD:__entity__ and physicians must utilize agents approved for other dermatology conditions",
|
165 |
"As ACD:__entity__ has been implicated in apoptosis-resistant glioblastoma (GBM), there is a high medical need for identifying novel ACD-inducing drugs ",
|
166 |
+
"Patients treated with anticancer chemotherapy drugs ( ACD:__entity__ ) are vulnerable to infectious diseases due to immunosuppression and to the direct impact of ACD on their intestinal microbiota ",
|
167 |
"In the LASOR:__entity__ trial:__entity__ , increasing daily imatinib dose from 400 to 600mg induced MMR at 12 and 24 months in 25% and 36% of the patients, respectively, who had suboptimal cytogenetic responses "
|
168 |
]
|
169 |
|